Mouse Anti-MYCN Recombinant Antibody (VS3-FY2814) (CAT#: VS3-FY2814)

This mouse anti-MYCN recombinant monoclonal antibody has been developed to target human MYCN protein, a calculated molecular weight of the protein is about 49.5 kDa. The optimal dilution for this antibody is Immunohistochemistry (1/50-1/200), Flow cytometry (1/50-1/200) and ELISA (1/1000-1/10000).

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
RNA Expression

Specifications

  • Host Species
  • Mouse
  • Type
  • Mouse IgG
  • Specificity
  • Human MYCN
  • Species Reactivity
  • Human
  • Applications
  • Immunohistochemistry, Flow cytometry, ELISA
  • Conjugate
  • Unconjugated, FITC
  • MW
  • The molecular weight of the target protein is approximately 49.5 kDa.
  • Related Disease
  • Feingold Syndrome 1 and Familial Retinoblastoma

Product Property

  • Clonality
  • Monoclonal Antibody
  • Format
  • Liquid
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C for short term (1-2 weeks). Aliquot and store at -20°C for long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • Immunohistochemistry: 1/50-1/200
    Flow cytometry: 1/50-1/200
    ELISA: 1/1000-1/10000

Target

  • Alternative Names
  • MYCN Proto-Oncogene, BHLH Transcription Factor; V-Myc Avian Myelocytomatosis Viral Oncogene Neuroblastoma Derived Homolog; Class E Basic Helix-Loop-Helix Protein 37; BHLHe37; NMYC; Neuroblastoma-Derived V-Myc Avian Myelocytomatosis Viral Related Oncogene; N-Myc Proto-Oncogene Protein
  • Cellular Localization
  • Nucleus
  • Post Translation Modifications
  • Phosphorylated by GSK3-beta which may promote its degradation (PubMed:24391509).
    Phosphorylated by AURKA (PubMed:27837025).
    (P04198-MYCN_HUMAN)
    Modification sites at PhosphoSitePlus (P04198)
    Modification sites at neXtProt (NX_P04198)
    Glycosylation from GlyGen (P04198) 1 site, 1 O-linked glycan (1 site)
  • Function
  • Positively regulates the transcription of MYCNOS in neuroblastoma cells.

Recommended Products

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "MYCN"

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for VS3-FY2814. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare